Inhibition of cytomegalovirus late antigen expression and cytomegalovirus replication in human fibroblasts and differentiated monocytic cells by liposome-encapsulated foscarnet

Journal of Controlled Release

Volumn 47, Issue 2, 1997, Pages 163-171

  Bergers, Joep J ^a,b   Hengge, Ulrich R ^c   Snijders, Susan V ^a   Bakker Woudenberg, Irma A J M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cytomegalovirus; Fibroblast; Foscarnet; Liposome; Macrophage; Virustatic therapy

Indexed keywords

FOSCARNET; LIPOSOME;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; CYTOTOXICITY; ENCAPSULATION; FIBROBLAST; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0030906755     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)01632-5     Document Type: Article

References (29)

1. D.A. Jabs, Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis, N. Engl. J. Med. 326 (1992) 213-220.
2. D.T. Dieterich, M.A. Poles, E.A. Lew, P.E. Mendez, R. Murphy, A. Addessi, J.T. Holbrook, K. Naughton and D.N. Friedberg, Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients, J. Infect. Dis. 167 (1993) 1184-1188.
3. D.A. Jabs, Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir, Infect. Agents Dis. 4 (1995) 131-142.
4. J. Sjövall, S. Bergdahl, G. Movin, S. Ogenstad and M. Saarimäki, Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection, Antimicrob. Agents Chemother. 33 (1989) 1023-1031.
5. U.R. Hengge, N.H. Brockmeyer, R. Malessa, U. Ravens and M. Goos, Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis, Antimicrob. Agents Chemother. 37 (1993) 1010-1014.
6. G. Deray, F. Martinez, C. Katlama, B. Levaltier, H. Beaufils, M. Danis, M. Rozenheim, A. Baumelou, E. Dohin, M. Gentilini and C. Jacobs, Foscarnet nephrotoxicity: mechanism, incidence and prevention, Am. J. Nephrol. 9 (1989) 316-321.
7. T.D. Heath, N.F. Lopez, W.H. Stern and D. Papahadjopoulos, 5-Fluoroorotate: a new liposome-dependent cytotoxic agent, FEBS Lett. 187 (1985) 73-75.
8. J. Mönkkönen and T.D. Heath, The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron, Calcif. Tissue Int. 53 (1993) 139-146.
9. J.J. Bergers, T.L.M. ten Hagen, E.W.M. van Etten and I.A.J.M. Bakker-Woudenberg, Liposomes as delivery systems in the prevention and treatment of infectious diseases, Pharm. World Sci. 17 (1995) 1-11.
10. J.W. Gnann, J. Ahlmén, C. Svalander, L. Olding, M.B.A. Oldstone and J.A. Nelson, Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus, Am. J. Pathol. 132 (1988) 239-248.
11. C.E. Ibanez, R. Schrier, P. Ghazal, C. Wiley and J.A. Nelson, Human cytomegalovirus productively infects primary differentiated macrophages, J. Virol. 65 (1991) 6581-6588.
12. R.F. Omar, N. Dusserre, A. Désormeaux, L. Poulin, M. Tremblay, D. Beauchamp and M.G. Bergeron, Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet, Antimicrob. Agents Chemother. 39 (1995) 1973-1978.
13. F.C. Szoka and C.J. Chu, Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes, Antimicrob. Agents Chemother. 132 (1988) 858-864.
14. C.J. Chu and F.C. Szoka, Antiviral activity and pharmacokinetics of liposome-encapsulated phosphonoformate in Rauscher murine leukemia virus-infected mice, J. Liposome Res. 2 (1992) 67-92.
15. H.O.C. Gümbel, D.G. Rückert, J. Cinatl, H. Rabenau, H.W. Doerr and C. Ohrloff, In vitro anti-human cytomegalovirus activity of liposome-encapsulated foscarnet, German J. Ophthalmol. 3 (1994) 5-8.
16. N. Dusserre, C. Lessard, N. Paquette, S. Perron, L. Poulin, M. Tremblay, D. Beauchamp, A. Désormeaux and M.G. Bergeron, Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics. AIDS 9 (1995) 833-841.
17. S. Tsuchiya, Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno and K. Tada, Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester, Cancer Res. 42 (1982) 1530-1536.
18. J.H. Senior, Fate and behavior of liposomes in vivo: a review of controlling factors, Crit. Rev. Ther. Drug Carrier Syst. 3 (1987) 123-193.
19. M.C. Woodle, K.K. Matthay, M.S. Newman, J.E. Hidayat, L.R. Collins, C. Redemann, F.J. Martin and D. Papahadjopoulos, Versatility in lipid composition showing prolonged circulation with sterically stabilized liposomes, Biochim. Biophys. Acta 1105 (1992) 193-200.
20. I.A.J.M. Bakker-Woudenberg, A.F. Lokerse, M.T. ten Kate, J.W. Mouton, M.C. Woodle and G. Storm, Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue, J. Infect. Dis. 168 (1993) 164-171.
21. I.A.J.M. Bakker-Woudenberg, M.C. Woodle and G. Storm, Long-circulating liposomes in the treatment of bacterial infections, in: D.D. Lasic and F.J. Martin (Eds.) Stealth Liposomes, Elsevier, Amsterdam, 1995, pp. 197-209.
22. S.K. Huang, K.-D. Lee, K. Hong, D.S. Friend and D. Papahadjopoulos, Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice, Cancer Res. 52 (1992) 5135-5143.
23. S. Warren and M.R. Williams, The acid-catalyzed decarboxylation of phosphonoformic acid, J. Chem. Soc. (B) (1971) 618-621.
24. G.R. Bartlett, Phosphorous assay in column chromatography, J. Biol. Chem. 234 (1959) 466-468.
25. E.G. Bligh and W.J. Dyer, A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol. 37 (1959) 911-917.
26. B.G. Weinshenker, S. Wilton and G.P.A. Rice, Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line, J. Immunol. 140 (1988) 1625-1631.
27. W.J. Waldman, W.H. Roberts, D.H. Davis, M.V. Williams, D.D. Sedmak and R.E. Stephens, Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells, Arch. Virol. 117 (1991) 143-164.
28. B. Öberg, Antiviral effects of phosphonoformate (PFA, foscarnet sodium), Pharmac. Ther. 40 (1988) 213-285.
29. F.C. Szoka and D. Papahadjopoulos, Comparative properties and methods of preparation of lipid vesicles (liposomes), Annu. Rev. Biophys. Bioeng. 9 (1980) 467-508.